Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Firms / A••••• H••••• V•••••••

A••••• H••••• V•••••••

Institutional venture firmHamburga•••••.vcSEC venture capital fund adviser

A••••• H••••• V••••••• is a transatlantic early stage Venture Capital firm actively co-founding and investing in age-related healthcare companies.

venture manager, reported GAV $197M across 4 vehicles

Importance
25
moderate
Active deployment
25
moderate
Emerging
0
low
Completeness
69
high
Freshness
98
high
Research priority
10
low
Identity and regulatory footprint
Headquarters
Hamburg, Germanyadviserinfo.sec.gov
Office address
GROSSE REICHENSTR. 27, Hamburg, 20457adviserinfo.sec.gov
Business phone
49 151 5110 7110adviserinfo.sec.gov
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Mar 25, 2024
Private funds reported
3 (3 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$197Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Owners on Schedule A
T••••••••• V••••••• I••••• G••• (Shareholder, A••••• V••••••• H•••••• G•••), C; A••••• V••••••• H•••••• G••• (Shareholder, Verwaltung A••••• Ventures G•••), E; T••••••••• I••••• G••• (Shareholder, A••••• V••••••• H•••••• G•••), C; T••••••••• G••• (Shareholder, T••••••••• V••••••• I••••• G•••), E; D•• M•••••••• Z••••• B••••••••• G••• (Shareholder, A••••• V••••••• H•••••• G•••), B
business email
info@apollo.vcapollo.vcpublished by the subject
business phone
49 151 5110 7110adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
Sectors
healthcare, biotech
Stages
seed, series a, series b, early
Geography
boston, europe
Check size
not stated; DFX does not estimate checks from round sizes
Self-described
venture capital
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
4 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
A••••• H••••• V••••••• F••• S•••Fund2024 form d first saleNewly closedunknownunknown$11.5M
of $11.5M
Aug 7, 2025
A••••• H••••• V••••••• F••• I• G••• • C•• K•FundunknownUnknown$196M
Mar 25, 2024
4unknownunknown
A••••• V••••••• C•••••••• F• L••• G••• • C•• K•SPV or co-invest vehicleunknownUnknown$679,390
Mar 25, 2024
1unknownunknown
A••••• V••••••• C•••••••• F•• L••• T•••••• L•• C•••••••• I• G••• • C•• K•SPV or co-invest vehicleunknownUnknown$123,352
Mar 25, 2024
1unknownunknown
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
21 current, 5 departed
J•• H••••••••• A••••
Managing Director, A••••• H••••• V••••••• Gp Ii G••• · since Jul 1, 2023
General partner
J••••••• O•• M••••••••
Shareholder, D•• M•••••••• Z••••• B••••••••• G••• · since May 1, 2020
Partner
S••••• D•••• L••••••
Chief Financial Officer, Verwaltung A••••• Ventures G••• · since Oct 1, 2019
Platform and operations
5 departed (kept with end dates)
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
10 dated events
  1. Sep 16, 2026
    P•••••• E••• (Associate) no longer on the team page of A••••• H••••• V•••••••
  2. Sep 16, 2026
    C•••• S•••••• (Venture Partner) no longer on the team page of A••••• H••••• V•••••••
  3. Sep 16, 2026
    A••• M••••• v•• H••••• (I•••••ment Director) no longer on the team page of A••••• H••••• V•••••••
  4. Sep 16, 2026
    A•••••• B•••••••• (Partner) no longer on the team page of A••••• H••••• V•••••••
  5. Jul 1, 2023
    J•• H••••••••• A•••• joined Schedule A of A••••• H••••• V••••••• as Managing Director, A••••• H••••• V••••••• Gp Ii G•••
  6. Mar 30, 2022
    A•••••••• S••••• B•••• (Shareholder, Asb H••••• Ventures G•••) no longer on Schedule A of A••••• H••••• V•••••••
  7. Apr 13, 2021
    A••••• H••••• V••••••• first filed Form ADV (ERA, venture capital fund adviser exemption)
  8. Apr 13, 2021
    A••••• V••••••• C•••••••• F•• L••• T•••••• L•• C•••••••• I• G••• • C•• K• first reported on Form ADV by A••••• H••••• V••••••• (Venture Capital Fund), GAV $124,097
  9. Apr 13, 2021
    A••••• H••••• V••••••• F••• I• G••• • C•• K• first reported on Form ADV by A••••• H••••• V••••••• (Venture Capital Fund), GAV $94,360,859
  10. Apr 13, 2021
    A••••• V••••••• C•••••••• F• L••• G••• • C•• K• first reported on Form ADV by A••••• H••••• V••••••• (Venture Capital Fund), GAV $443,283
Classification history
  1. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $197M across 4 vehicles
  2. Sep 12, 2026
    Institutional venture firm (confirmed, 95%, cls-1)
    venture manager, reported GAV $197M across 3 vehicles
Evidence
32 observations from 2 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC exemption claimedventure_capital_fund_adviserMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2021-04-13Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2024-03-25Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds1Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone49 151 5110 7110Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
DescriptionA••••• H••••• V••••••• is a transatlantic early stage Venture Capital firm actively co-founding and investing in age-related healthcare companies.
meta description
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionA••••• H••••• V••••••• is a transatlantic early stage Venture Capital firm actively co-founding and investing in age-related healthcare companies.
meta description
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersHamburg, GermanyMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office addressGROSSE REICHENSTR. 27, Hamburg, 20457Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Self-described typeventure_capital
A••••• H••••• V••••••• is a transatlantic early stage Venture Capital firm actively co-founding and investing in transformative healthcare companies targeting age-related diseases and aging itself.
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Self-described typeventure_capital
A••••• H••••• V••••••• is a transatlantic early stage Venture Capital firm actively co-founding and investing in transformative healthcare companies targeting age-related diseases and aging itself.
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Legal formOther (specify)Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private funds reported3Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$197MMar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated geographyboston,europe
geography words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated geographyboston,europe
geography words on the home page
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorshealthcare,biotech
sector words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorshealthcare,biotech
sector words on the home page
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated stagesseed,series_a,series_b,early
stage words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated stagesseed,series_a,series_b,early
stage words on the home page
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://a•••••.vc/
17 name/title pairs read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://a•••••.vc/
16 name/title pairs read
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported3Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Websitehttps://a•••••.vc/Mar 25, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleA••••• H••••• V•••••••
title tag
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleA••••• H••••• V•••••••
title tag
Sep 12, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)